These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 11388336)
1. [Pravastatin and the development of diabetes mellitus. Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study]. Comaschi MA; Menozzi F Ital Heart J Suppl; 2001 May; 2(5):556-8. PubMed ID: 11388336 [No Abstract] [Full Text] [Related]
2. Long-term follow-up of the West of Scotland Coronary Prevention Study. McEvoy JW; Margey R; Blake GJ N Engl J Med; 2008 Jan; 358(2):193; author reply 194-5. PubMed ID: 18184967 [No Abstract] [Full Text] [Related]
3. [WOSCOPS [West of Scotland Coronary Prevention Study]]. Furutani N; Tada N Nihon Rinsho; 2001 Mar; 59 Suppl 3():387-92. PubMed ID: 11347100 [No Abstract] [Full Text] [Related]
4. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS). Lim PO; Yee KM Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109 [No Abstract] [Full Text] [Related]
5. Long-term follow-up of the West of Scotland Coronary Prevention Study. DeFilippis AP; Bansal S; Blumenthal RS N Engl J Med; 2008 Jan; 358(2):194; author reply 194-5. PubMed ID: 18193527 [No Abstract] [Full Text] [Related]
6. Long-term follow-up of the West of Scotland Coronary Prevention Study. Tsubokura M; Kami M N Engl J Med; 2008 Jan; 358(2):193-4; author reply 194-5. PubMed ID: 18193526 [No Abstract] [Full Text] [Related]
8. Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project. Simes J; Furberg CD; Braunwald E; Davis BR; Ford I; Tonkin A; Shepherd J Eur Heart J; 2002 Feb; 23(3):207-15. PubMed ID: 11792135 [TBL] [Abstract][Full Text] [Related]
9. [Statin treatment in type 2 diabetes. Is it a must today?]. Faust M MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527 [No Abstract] [Full Text] [Related]
10. [Long-term follow-up of the West of Scotland Coronary Prevention Study]. Liakishev AA Kardiologiia; 2007; 47(12):65-6. PubMed ID: 18260982 [No Abstract] [Full Text] [Related]
11. Effect of statin treatment on coronary collateral development in patients with diabetes mellitus. Dincer I; Ongun A; Turhan S; Ozdol C; Ertas F; Erol C Am J Cardiol; 2006 Mar; 97(6):772-4. PubMed ID: 16516573 [TBL] [Abstract][Full Text] [Related]
12. Statins for high-risk patients without heart disease or high cholesterol. Med Lett Drugs Ther; 2006 Jan; 48(1225):1-3. PubMed ID: 16374400 [No Abstract] [Full Text] [Related]
13. Effect of pravastatin in people with diabetes and chronic kidney disease. Tonelli M; Keech A; Shepherd J; Sacks F; Tonkin A; Packard C; Pfeffer M; Simes J; Isles C; Furberg C; West M; Craven T; Curhan G J Am Soc Nephrol; 2005 Dec; 16(12):3748-54. PubMed ID: 16251235 [TBL] [Abstract][Full Text] [Related]
14. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study. Hague W; Forder P; Simes J; Hunt D; Tonkin A; Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760 [TBL] [Abstract][Full Text] [Related]
15. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Brouilette SW; Moore JS; McMahon AD; Thompson JR; Ford I; Shepherd J; Packard CJ; Samani NJ; Lancet; 2007 Jan; 369(9556):107-14. PubMed ID: 17223473 [TBL] [Abstract][Full Text] [Related]
16. The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease. Ledmyr H; McMahon AD; Ehrenborg E; Nielsen LB; Neville M; Lithell H; MacFarlane PW; Packard CJ; Karpe F; Circulation; 2004 May; 109(19):2279-84. PubMed ID: 15136504 [TBL] [Abstract][Full Text] [Related]
17. Do statins reduce the risk for diabetes by improving exercise capacity? Ur E; Shlossberg A Circulation; 2001 Nov; 104(20):E104-5. PubMed ID: 11705835 [No Abstract] [Full Text] [Related]
18. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Freeman DJ; Norrie J; Sattar N; Neely RD; Cobbe SM; Ford I; Isles C; Lorimer AR; Macfarlane PW; McKillop JH; Packard CJ; Shepherd J; Gaw A Circulation; 2001 Jan; 103(3):357-62. PubMed ID: 11157685 [TBL] [Abstract][Full Text] [Related]
19. Expected versus observed survival in 3 large population studies with HMG-CoA reductase inhibitors. Naslafkih A; Sestier F J Insur Med; 2000; 32(3):155-62. PubMed ID: 15912915 [TBL] [Abstract][Full Text] [Related]
20. Statins and renal function. Is the compound and dose making a difference? Athyros VG; Karagiannis A; Kakafika A; Elisaf M; Mikhailidis DP Nephrol Dial Transplant; 2007 Mar; 22(3):963-4; author reply 964. PubMed ID: 17255130 [No Abstract] [Full Text] [Related] [Next] [New Search]